A good candidate has no history of neuromuscular disease, no previous allergic reactions to Botox or lidocaine (please mention these to us, as we have different options available for patients with allergies), and is not pregnant or breastfeeding
GLP-1 expenses may be reimbursed when supported by a prescription or letter of medical necessity, depending on plan design
Patients who move through titration thoughtfully tend to experience fewer disruptions, better appetite stability, and greater confidence in their treatment plan
XERF is designed to be a comfortable experience
As of September 2023 it is on the FDA's Category 2 list of bulk drug substances that may not be compounded due to significant safety risks, and the agency has scheduled a Pharmacy Compounding Advisory Committee (PCAC) review for July 2026 covering proposed uses in opioid withdrawal, chronic insomnia, and narcolepsy
Recovery, sleep, and alternating intensity levels improve long-term progress